Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Colorcon
McKinsey
Medtronic
Chubb
Farmers Insurance

Generated: May 20, 2019

DrugPatentWatch Database Preview

Details for Patent: 7,368,460

« Back to Dashboard

Which drugs does patent 7,368,460 protect, and when does it expire?

Patent 7,368,460 protects SELZENTRY and is included in two NDAs.

This patent has ninety-six patent family members in fifty-five countries.

Summary for Patent: 7,368,460
Title:Tropane derivatives useful in therapy
Abstract:The present invention provides compounds of the formula: ##STR00001## wherein R.sup.1 is C.sub.3-6 cycloalkyl optionally substituted by one or more fluorine atoms, or C.sub.1-6 alkyl optionally substituted by one or more fluorine atoms, or C.sub.3-6 cycloalkylmethyl optionally ring-substituted by one or more fluorine atoms; and R.sup.2 is phenyl optionally substituted by one or more fluorine atoms, to pharmaceutically acceptable salts and solvates thereof, and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such compounds.
Inventor(s): Perros; Manoussos (Sandwich, GB), Price; David Anthony (Sandwich, GB), Stammen; Blanda Luzia Christa (Sandwich, GB), Wood; Anthony (Sandwich, GB)
Assignee: Pfizer, Inc. (New York, NY)
Application Number:10/678,836
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 7,368,460
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 7,368,460

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Viiv Hlthcare SELZENTRY maraviroc SOLUTION;ORAL 208984-001 Nov 4, 2016 RX Yes Yes ➤ Sign Up ➤ Sign Up METHOD OF TREATING PATIENTS INFECTED WITH CCR5-TROPIC HIV-1 ➤ Sign Up
Viiv Hlthcare SELZENTRY maraviroc TABLET;ORAL 022128-003 Nov 4, 2016 RX Yes No ➤ Sign Up ➤ Sign Up METHOD OF TREATING PATIENTS INFECTED WITH CCR5-TROPIC HIV-1 ➤ Sign Up
Viiv Hlthcare SELZENTRY maraviroc TABLET;ORAL 022128-004 Nov 4, 2016 RX Yes No ➤ Sign Up ➤ Sign Up METHOD OF TREATING PATIENTS INFECTED WITH CCR5-TROPIC HIV-1 ➤ Sign Up
Viiv Hlthcare SELZENTRY maraviroc TABLET;ORAL 022128-001 Aug 6, 2007 RX Yes No ➤ Sign Up ➤ Sign Up METHOD OF TREATING PATIENTS INFECTED WITH CCR5-TROPIC HIV-1 ➤ Sign Up
Viiv Hlthcare SELZENTRY maraviroc TABLET;ORAL 022128-002 Aug 6, 2007 RX Yes Yes ➤ Sign Up ➤ Sign Up METHOD OF TREATING PATIENTS INFECTED WITH CCR5-TROPIC HIV-1 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,368,460

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0014046.7May 26, 2000
United Kingdom0015835.2Jun 27, 2000

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Fish and Richardson
Covington
Medtronic
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.